Chemotherapy

International clinical trial exploring treatment combinations for rare and aggressive cancers in women launched in Australia

Translational findings and higher major pathological response support combinations over monotherapy before surgery

CAR T-cell therapy targeting TAG-72 and other markers is in the first-in-human Phase 1 trial

A 64-protein pattern could identify which patients would or wouldn’t benefit from standard ovarian cancer treatments

Nivolumab/ipilimumab immunotherapy showed results comparable to response rates and survival benefits conferred by chemotherapy

Identifying the right set of patients using a molecular test can help effectively deliver a personalized, chemotherapy-free treatment regimen

Join Today's Clinical Lab and David Miklos, MD, PhD, to discuss recent advances in bispecific CAR-T therapy and biomarkers for characterizing CAR-T product quality

Heating up cancer cells while targeting them with chemotherapy was more effective than the chemotherapy alone

Light scattering technique helps personalize chemotherapy treatments

De-escalation of treatment strategies aims to minimize toxicity while maintaining efficacy